We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
+4.28%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$447M
AUM Growth
+$34.4M
Cap. Flow
+$25.4M
Cap. Flow %
5.68%
Top 10 Hldgs %
63.53%
Holding
36
New
5
Increased
15
Reduced
9
Closed
7

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JNJ icon
26
Johnson & Johnson
JNJ
$599B
$4.38M 0.98%
+26,471
New +$4.27M
LNTH icon
27
Lantheus
LNTH
$6.8B
$4.22M 0.94%
+50,309
New +$4.51M
VIR icon
28
Vir Biotechnology
VIR
$1.56B
$3.69M 0.83%
150,406
+4,861
+3% +$122K
PTCT icon
29
PTC Therapeutics
PTCT
$6.47B
$2.3M 0.51%
56,577
+1,671
+3% +$81.8K
BIO icon
30
Bio-Rad Laboratories Class A
BIO
$8.08B
-13,617
Closed -$6.52M
BNTX icon
31
BioNTech
BNTX
$23.3B
-26,554
Closed -$3.31M
BSX icon
32
Boston Scientific
BSX
$65.1B
-162,397
Closed -$8.12M
CVS icon
33
CVS Health
CVS
$137B
-38,310
Closed -$2.85M
ILMN icon
34
Illumina
ILMN
$27.9B
-24,340
Closed -$5.51M
MRK icon
35
Merck
MRK
$307B
-56,153
Closed -$5.97M
SGEN
36
DELISTED
Seagen Inc. Common Stock
SGEN
-36,000
Closed -$7.29M

Similar funds

Sector Gamma AS's Q2 2023 Portfolio in Review

As of Q2 2023, Sector Gamma AS held 36 positions worth $447M, up 8.4% from $412M the previous quarter. Its ten largest holdings account for 64% of the portfolio.

Sector Gamma AS deployed $25.4M of net new capital in Q2 2023, opening 5 new positions and adding to 15 existing holdings. Its largest new stake was Becton Dickinson: 92,923 shares worth $24.5M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

On the sell side, the largest reduction was Qiagen, an estimated $6.06M trimmed.

  • Sector Gamma AS's largest Q2 2023 buy was Becton Dickinson: 92,923 shares worth $24.5M.
  • Sector Gamma AS added most to Baxter International in Q2 2023, an estimated $13.4M increase.
  • Sector Gamma AS's biggest Q2 2023 reduction was Qiagen, cutting an estimated $6.06M.
  • Sector Gamma AS fully exited Boston Scientific in Q2 2023, selling an estimated $8.12M.
  • Sector Gamma AS's ten largest holdings make up 64% of its $447M portfolio in Q2 2023.
  • Sector Gamma AS opened 5 new positions and closed 7 in Q2 2023.
  • Sector Gamma AS's portfolio value rose 8.4% quarter-over-quarter to $447M.

Based on Sector Gamma AS's 13F filing for Q2 2023, filed 9 Aug 2023.